By purchasing our forecast for ZOETIS INC. (ZTS) for the period of 1 month and 28 days, you can gain valuable insights into the changes in value and dynamics of this stock. Our unique forecast will provide you with accurate predictions for December 2024, January 2025, February 2025, March 2025, and April 2025.
Knowing how the cost of ZTS will change during these months is crucial for making informed investment decisions and maximizing your earning potential. Whether the cost will rise or fall, our forecast will help you choose the most suitable strategy to capitalize on these fluctuations.
Diversifying your portfolio is essential for reducing risk and increasing profitability. Our forecast will enable you to identify the potential growth or decline of ZTS, allowing you to adjust your portfolio accordingly.
Stay ahead of the game by regularly checking for new forecasts on our website. Being aware of the entire investment period will empower you to make well-informed decisions and seize opportunities as they arise. Don't miss out on the benefits of our accurate and reliable forecast for ZOETIS INC. (ZTS).
Zoetis Inc., a leading global animal health company, has caught the attention of investors as Xponance Inc. recently acquired 2814 shares of its stock....
Zoetis Inc. (NYSE:ZTS) has been gaining attention from investors as short interest in the company continues to rise....
Hedge funds have shown great interest in Zoetis Inc. (NYSE:ZTS) as the best pharma stock to buy....
Zoetis Inc., a leading animal health company, has recently announced a higher return on equity (ROE) compared to its industry peers....
Zoetis Inc., a leading global animal health company, has recently reported a higher return on equity (ROE) compared to its industry counterparts....
Zoetis Inc., a leading animal health company, has recently surpassed industry expectations by delivering a remarkable Return on Equity (ROE) performance....
Zoetis Inc. (NYSE:ZTS), a leading animal health company, has reported a better return on equity (ROE) compared to its industry counterparts....
Zoetis Inc., a leading animal health company, recently announced its impressive Q4 2024 earnings results. The company reported strong revenue growth, driven by innovative products and strategic initiatives....
Zoetis Inc., a leading animal health company, announced impressive results in its Q4 2024 earnings call. The company reported strong revenue growth and highlighted its strategic innovations....
Zoetis Inc., a leading global animal health company, recently announced its impressive Q4 performance, exceeding Wall Street estimates for key metrics....
Zoetis Inc., a leading animal health company, recently released its fourth-quarter financial results, showcasing a robust balance sheet and impressive performance....
Zoetis Inc. (NYSE:ZTS), a leading global animal health company, has been attracting the attention of investors as it prepares to report its upcoming earnings....
Animal health company Zoetis Inc. has reported strong earnings growth in its latest financial report, according to sources....
Zoetis Inc., a leading animal health company, has announced an increase in its quarterly dividend. The company declared a dividend of $0.50 per share, payable on June 2025....
Sivik Global Healthcare LLC has recently purchased new shares in Zoetis Inc. (NYSE: ZTS), indicating a bullish case theory for the company....
Zoetis Inc., a leading global animal health company, is experiencing impressive growth and shows promising prospects for the future....
Pharmaceutical company Zoetis Inc (NYSE:ZTS) has been making significant strides in the animal health industry....
Zoetis Inc., a leading animal health company, has recently witnessed a surge in its stock position. Blue Trust Inc....
Zoetis Inc., a leading global animal health company, has once again outperformed its industry peers with a better Return on Equity (ROE)....
Zoetis Inc., a leading animal health company, has reported a higher return on equity (ROE) than its industry counterparts....
Stock ticker: | ZTS |
Name: | ZOETIS INC. |
Sector: | Healthcare |
Investing Risk: | MEDIUM |
Forecast length: | 6 months, 16 days |
Accuracy: | 26.32 % |
Average profit per target: | 9.82 % |